Shares fell after the company cut its full-year guidance on the back of challenging macroeconomic conditions and ...

Merck KGaA reduced its outlook for sales and profit growth this year, citing the impact of a weak US dollar and uncertainty ...

German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

By Ludwig Burger FRANKFURT (Reuters) -German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more ...

FRANKFURT (Reuters) -German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more cautiously for ...

Merck plans to spend $895 million to expand a De Soto, Kansas, manufacturing facility for its animal health segment, the ...

Merck Foundation partners with African First Ladies and others to tackle diabetes and hypertension through education and ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. | ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.